Issuu on Google+

Taiwan Liposome Company, Ltd. - Product Pipeline Review – 2013 Order report by calling ReportsnReports.com at +1 888 391 5441 OR send an email on sales@reportsandreports.com with Taiwan Liposome Company, Ltd. Product Pipeline Review – 2013 in subject line and your contact details. The pharmaceuticals report, Taiwan Liposome Company, Ltd. - Product Pipeline Review 2013 provides data on the Taiwan Liposome Company, Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. This report is built using data and information sourced from proprietary databases, Taiwan Liposome Company, Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from Taiwan Liposome Company, Ltd. and industry-specific third party sources. Scope of The Report - Taiwan Liposome Company, Ltd. - Brief Taiwan Liposome Company, Ltd. overview including business description, key information and facts, and its locations and subsidiaries. - Review of current pipeline of Taiwan Liposome Company, Ltd. human therapeutic division. - Overview of pipeline therapeutics across various therapy areas. - Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe. - Product profiles for late stage and clinical stage products of Taiwan Liposome Company, Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones. - Recent updates of the Taiwan Liposome Company, Ltd.’s pipeline in the last quarter. - Key discontinued and dormant projects. - Latest news and deals relating to the products. Complete report is spread across 29 pages and available @ http://www.reportsnreports.com/reports/273540-taiwan-liposome-company-ltdproduct-pipeline-review-2013.html. Reasons to buy the Report Taiwan Liposome Company, Ltd. - Product Pipeline Review – 2013 - Evaluate Taiwan Liposome Company, Ltd.’s strategic position with total access to detailed information on its product pipeline. - Assess the growth potential of Taiwan Liposome Company, Ltd. in its therapy areas of focus. - Identify new drug targets and therapeutic classes in the Taiwan Liposome Company, Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

Taiwan Liposome Company, Ltd. - Product Pipeline Review - 2013


- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps. - Exploit collaboration and partnership opportunities with Taiwan Liposome Company, Ltd.. - Avoid Intellectual Property Rights related issues. - Explore the dormant and discontinued projects of Taiwan Liposome Company, Ltd. and identify potential opportunities in those areas. Buy a copy of report @ http://www.reportsnreports.com/purchase.aspx? name=273540. Key Facts 5 Taiwan Liposome Company, Ltd. - Research and Development Overview 6 Key Therapeutic Areas 6 Taiwan Liposome Company, Ltd. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Taiwan Liposome Company, Ltd. - Pipeline Products Glance 10 Taiwan Liposome Company, Ltd. - Clinical Stage Pipeline Products 10 Phase II Products/Combination Treatment Modalities 10 Taiwan Liposome Company, Ltd. - Early Stage Pipeline Products 11 IND/CTA Filed Products/Combination Treatment Modalities 11 Preclinical Products/Combination Treatment Modalities 12 Taiwan Liposome Company, Ltd. - Drug Profiles 13 List of Tables Taiwan Liposome Company, Ltd., Key Information 5 Taiwan Liposome Company, Ltd., Key Facts 5 Taiwan Liposome Company, Ltd. - Pipeline by Indication, 2013 7 Taiwan Liposome Company, Ltd. - Pipeline by Stage of Development, 2013 8 Taiwan Liposome Company, Ltd. - Monotherapy Products in Pipeline, 2013 9 Taiwan Liposome Company, Ltd. - Phase II, 2013 10 Taiwan Liposome Company, Ltd. - IND/CTA Filed, 2013 11 Taiwan Liposome Company, Ltd. - Preclinical, 2013 12 Taiwan Liposome Company, Ltd. - Pipeline by Therapeutic Class, 2013 20 Taiwan Liposome Company, Ltd. - Pipeline by Target, 2013 21 Taiwan Liposome Company, Ltd. - Pipeline by Route of Administration, 2013 22 Taiwan Liposome Company, Ltd. - Pipeline by Molecule Type, 2013 23 Taiwan Liposome Company, Ltd. - Pipeline Products by Mechanism of Action, 2013 24 Taiwan Liposome Company, Ltd. - Recent Pipeline Updates, 2013 25 Taiwan Liposome Company, Ltd. - Dormant Developmental Projects,2013 26 Taiwan Liposome Company, Ltd., Subsidiaries 27 Inquiry Before Buying @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=273540

Taiwan Liposome Company, Ltd. - Product Pipeline Review - 2013


List of Figures Taiwan Liposome Company, Ltd. - Pipeline by Top 10 Indication, 2013 7 Taiwan Liposome Company, Ltd. - Pipeline by Stage of Development, 2013 8 Taiwan Liposome Company, Ltd. - Monotherapy Products in Pipeline, 2013 9 Taiwan Liposome Company, Ltd. - Pipeline by Top 10 Therapeutic Class, 2013 19 Taiwan Liposome Company, Ltd. - Pipeline by Top 10 Target, 2013 21 Taiwan Liposome Company, Ltd. - Pipeline by Top 10 Route of Administration, 2013 22 Taiwan Liposome Company, Ltd. - Pipeline by Top 10 Molecule Type, 2013 23 Taiwan Liposome Company, Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2013 24 Inquire for Discount @ http://www.reportsnreports.com/contacts/discount.aspx? name=273540. Explore more reports by Global Markets Direct on pipeline reviews and other related topics. Contact sales@reportsandreports.com / Call +1 888 391 5441 for further information on “Taiwan Liposome Company, Ltd. - Product Pipeline Review - 2013� report OR for any other market research and intelligence needs you may have for your business.

Taiwan Liposome Company, Ltd. - Product Pipeline Review - 2013


Product Pipeline Review 2013: Taiwan Liposome Company, Ltd.